BG17385A1 - - Google Patents
Info
- Publication number
- BG17385A1 BG17385A1 BG1896271A BG1896271A BG17385A1 BG 17385 A1 BG17385 A1 BG 17385A1 BG 1896271 A BG1896271 A BG 1896271A BG 1896271 A BG1896271 A BG 1896271A BG 17385 A1 BG17385 A1 BG 17385A1
- Authority
- BG
- Bulgaria
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BG1896271A BG17385A1 (de) | 1971-11-09 | 1971-11-09 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BG1896271A BG17385A1 (de) | 1971-11-09 | 1971-11-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
BG17385A1 true BG17385A1 (de) | 1973-11-10 |
Family
ID=3898183
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG1896271A BG17385A1 (de) | 1971-11-09 | 1971-11-09 |
Country Status (1)
Country | Link |
---|---|
BG (1) | BG17385A1 (de) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7064128B2 (en) | 1998-06-30 | 2006-06-20 | Neuromed Technologies, Inc. | Preferentially substituted calcium channel blockers |
US7186726B2 (en) | 1998-06-30 | 2007-03-06 | Neuromed Pharmaceuticals Ltd. | Preferentially substituted calcium channel blockers |
-
1971
- 1971-11-09 BG BG1896271A patent/BG17385A1/xx unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7064128B2 (en) | 1998-06-30 | 2006-06-20 | Neuromed Technologies, Inc. | Preferentially substituted calcium channel blockers |
US7186726B2 (en) | 1998-06-30 | 2007-03-06 | Neuromed Pharmaceuticals Ltd. | Preferentially substituted calcium channel blockers |